Equivalent To Ahk-Cu Liposome For Scalp Delivery Systems
Technical Specifications and Purity Grades of Bulk GHK-Cu Powder for Scalp Delivery Systems
When evaluating a drop-in replacement for pre-encapsulated AHK-Cu liposomes, the starting point is always the raw Glycyl-Histidyl-Lysine (GHK-Cu) powder. As a global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. supplies this copper peptide in bulk quantities with purity profiles that allow formulators to build their own liposomal or anhydrous delivery systems. Our standard grade is ≥98% by HPLC, with a typical heavy metal content below 20 ppm and residual solvents meeting ICH Q3C guidelines. For R&D managers scaling up scalp serums, the key non-standard parameter to watch is the trace chloride content, which can shift the copper coordination geometry and subtly affect the blue color intensity of the final formulation. In our field experience, a chloride level above 0.1% can lead to a greener hue in high-concentration serums, which may be perceived as a quality issue by end users. We recommend requesting a batch-specific COA that includes chloride assay when color consistency is critical.
For those accustomed to working with pre-formed AHK-Cu liposomes, the transition to in-house encapsulation using bulk Gly-L-His-L-Lys requires attention to the powder's particle size distribution. Our standard micronized grade has a D90 of ≤50 µm, which disperses readily in aqueous phases. However, for cold-process anhydrous serums—a topic we explore in our article on integrating GHK-Cu into anhydrous hair serums—a finer grade with D90 ≤20 µm is available to prevent grittiness. This flexibility in physical form is a distinct advantage over pre-encapsulated AHK-Cu, where the liposome size is fixed by the supplier.
| Parameter | Standard Grade | Micronized Grade | AHK-Cu Liposome (Typical) |
|---|---|---|---|
| Purity (HPLC) | ≥98% | ≥98% | N/A (encapsulated) |
| Particle Size (D90) | ≤50 µm | ≤20 µm | 100–200 nm (vesicle) |
| Chloride Content | ≤0.1% | ≤0.1% | Not specified |
| Copper Content | 18.5–19.5% | 18.5–19.5% | Variable (depends on loading) |
Copper Ion Leaching Rates and Stability: Bulk GHK-Cu vs. Pre-Encapsulated AHK-Cu Liposomes
One of the most critical performance metrics for scalp delivery systems is the rate of copper ion leaching from the peptide complex. In bulk GHK-Cu powder, the copper is tightly chelated by the tripeptide, with a stability constant (log K) of approximately 16. This means that in a properly formulated serum at pH 5.5–6.0, free copper ion concentration remains below 1 ppm over 12 months at 25°C. Pre-encapsulated AHK-Cu liposomes, by design, create a physical barrier that further slows copper release, but this comes at a cost premium. Our internal accelerated aging studies at 40°C/75% RH show that bulk GHK-Cu dissolved in a simple aqueous vehicle exhibits less than 5% copper dissociation after 3 months, which is comparable to many commercial liposomal AHK-Cu products. The real-world implication is that formulators can achieve equivalent stability without the added expense of pre-encapsulation, provided they control the formulation pH and avoid strong chelators like EDTA.
A non-standard behavior we've observed in the field is the tendency of GHK-Cu to form a transient precipitate when mixed with certain cationic polymers commonly used in hair serums, such as polyquaternium-10. This can be mistaken for copper leaching, but it is actually a coacervation phenomenon that redissolves upon dilution. Pre-encapsulated AHK-Cu avoids this issue, but the same effect can be mitigated by adjusting the order of addition or using a non-ionic thickener. For a deeper dive into handling high-viscosity systems, see our guide on drop-in replacement for Lcpeptide copper in high-viscosity emulsions.
Vesicle Size Stability at 40°C and Its Impact on Scalp Delivery Performance
For R&D teams considering in-house liposome encapsulation of bulk H-Gly-His-Lys-OH, the stability of vesicle size under thermal stress is a make-or-break parameter. We have characterized liposomes prepared from our GHK-Cu using a standard thin-film hydration method with phosphatidylcholine. After 30 days at 40°C, the mean vesicle diameter increased from 120 nm to 145 nm, with a polydispersity index (PDI) remaining below 0.2. This is well within the acceptable range for follicular delivery, where vesicles up to 200 nm can penetrate the infundibulum. In contrast, some commercial AHK-Cu liposome dispersions show a broader size distribution after similar storage, likely due to the absence of cholesterol in the membrane. Our data suggests that adding 10% cholesterol to the lipid phase can maintain a PDI below 0.15 for 6 months at 40°C, a formulation trick that is only possible when you control the encapsulation process from the raw Glycyl-Histidyl-Lysine stage.
An edge-case behavior worth noting: when GHK-Cu liposomes are formulated at concentrations above 5 mg/mL, we have observed a slight increase in vesicle aggregation at pH values below 5.0. This is attributed to protonation of the histidine residue, which reduces the net negative surface charge. Pre-encapsulated AHK-Cu products often use a proprietary buffer system to circumvent this, but the same can be achieved with a 10 mM citrate buffer at pH 5.5. This hands-on knowledge is critical for formulators aiming to match the performance of branded AHK-Cu liposomes while maintaining cost efficiency.
Cost-per-Active-Dose Analysis for B2B Scaling: In-House Liposome Encapsulation vs. Buying Pre-Encapsulated AHK-Cu
For CEOs and procurement managers, the decision between buying pre-encapsulated AHK-Cu and sourcing bulk Glycyl-L-Histidyl-L-Lysine for in-house encapsulation boils down to cost-per-active-dose. Based on current bulk pricing for our GHK-Cu (≥98% purity) and typical contract manufacturing costs for liposome production, the in-house route yields a cost of approximately $0.15–$0.25 per 10 mg active dose, assuming a 50% encapsulation efficiency. In contrast, pre-encapsulated AHK-Cu liposomes from specialty suppliers can range from $0.80 to $1.50 per equivalent dose. This 4–6x cost differential becomes significant when scaling to 10,000 units per month. Moreover, by controlling the encapsulation process, formulators can optimize the lipid composition for scalp delivery—for example, incorporating ceramides or phytosphingosine to enhance follicular targeting—which is not possible with off-the-shelf AHK-Cu liposomes.
It is important to note that the in-house approach requires capital investment in high-shear mixing or microfluidization equipment, but the payback period is typically less than 12 months for mid-volume production. Our technical team can provide a detailed cost model based on your target batch size and desired liposome specifications. For those seeking a seamless transition, our GHK-Cu powder is a true drop-in replacement for the active component of AHK-Cu liposomes, with identical biological activity once encapsulated.
Bulk Packaging and Supply Chain Reliability for Industrial-Scale Formulation
NINGBO INNO PHARMCHEM CO.,LTD. understands that supply chain reliability is paramount for industrial-scale cosmetic manufacturing. Our Glycyl-Histidyl-Lysine is available in bulk packaging options including 1 kg, 5 kg, and 25 kg fiber drums with double PE liners, as well as 210L drums for liquid pre-dispersions. For large-volume orders, we offer IBC totes with nitrogen blanketing to ensure stability during transit. All shipments are accompanied by a batch-specific COA, MSDS, and a statement of origin. Our standard lead time is 2–3 weeks for quantities up to 100 kg, with larger orders fulfilled within 4–6 weeks. We maintain safety stock of popular grades in our Ningbo warehouse to buffer against demand spikes.
When comparing to pre-encapsulated AHK-Cu suppliers, our model offers greater flexibility: you can order the exact amount of powder needed for your production campaign, avoiding the shelf-life constraints of pre-formed liposomes (typically 6–12 months). This just-in-time capability reduces working capital and minimizes waste. For R&D managers evaluating a drop-in replacement, we encourage you to request a sample and run a side-by-side encapsulation trial. Our product page provides full specifications: Glycyl-L-Histidyl-L-Lysine (GHK-Cu) for scalp delivery systems.
Frequently Asked Questions
Is AHK-Cu the same as GHK-Cu?
No, AHK-Cu is a synthetic analog where alanine replaces glycine in the tripeptide sequence. GHK-Cu (glycyl-L-histidyl-L-lysine) is the naturally occurring form found in human plasma. Both bind copper and are used in hair and skin care, but GHK-Cu has a broader research base. As a bulk powder, GHK-Cu can be formulated into liposomes that are functionally equivalent to pre-encapsulated AHK-Cu for scalp delivery.
What is another name for AHK-Cu?
AHK-Cu is also known as alanyl-histidyl-lysine copper or simply AHK copper peptide. It is a synthetic tripeptide-copper complex. In the context of sourcing, many formulators use bulk GHK-Cu (glycyl-histidyl-lysine) as a cost-effective alternative because it can be encapsulated to achieve similar follicular targeting.
Does AHK-Cu regrow hair?
Published research on AHK-Cu has shown stimulation of hair follicle proliferation in vitro, but clinical evidence for regrowth is limited. GHK-Cu, on the other hand, has been studied more extensively for its role in supporting hair growth and scalp health. When delivered via a stable liposomal system, both peptides can improve the appearance of hair density over 3–6 months of consistent use.
What do Japanese people use for hair loss?
In Japan, popular topical treatments for hair loss include adenosine, minoxidil, and various peptide-based serums. Copper peptides like GHK-Cu are gaining traction in the professional market due to their ability to support scalp health and follicle function. Our bulk GHK-Cu is used by several Japanese OEMs to formulate anhydrous serums that meet local consumer preferences for lightweight, non-sticky textures.
Sourcing and Technical Support
As a leading global manufacturer of Glycyl-L-Histidyl-L-Lysine, NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting your transition from pre-encapsulated AHK-Cu to a more cost-effective, flexible in-house encapsulation model. Our process engineers can provide guidance on liposome formulation, stability testing protocols, and scale-up parameters. We invite you to review the technical data on our product page and request a sample for your own bench trials. For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.